- Metronomic capecitabine versus doxorubicin in advanced hepatocellular carcinoma
-
Khedr GA, Elzawawy S, Gowil AG, Elyamany A, Eshafei M
- KMID: 2360701
- Korean J Clin Oncol.
- 2016 Jun;12(1):32-40.
- doi: 10.14216/kjco.16006
PURPOSE: We evaluated oral metronomic capecitabine (MC) compared to intravenous doxorubicin in patients with advanced or metastatic hepatocellular carcinoma (HCC). METHODS: From January 2013 to December 2015, patients with Child-Pugh class... -
- CITED
-
- Close
- SHARE
-
- Close
